Protein phosphatases in pathological cardiac hypertrophy
Pathological cardiac hypertrophy is a pathological change of various cardiovascular disease, caused by persistent mechanical and chemical stimulation, which ultimately leads to heart failure and arrhythmia. The clinical therapeutic means of prevention cannot be satisfied by the prevention and treatm...
Saved in:
| Main Authors: | ZHANG Xutao, XIA Hao |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Editorial Office of New Medicine
2024-04-01
|
| Series: | Yixue xinzhi zazhi |
| Subjects: | |
| Online Access: | https://yxxz.whuznhmedj.com/futureApi/storage/attach/2404/Wi0IPmvmCvUD0Fn4Pyn7OG6B6RUeOae4HnEVumJf.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nuclear receptor corepressor 1 represses cardiac hypertrophy
by: Chao Li, et al.
Published: (2019-09-01) -
Deubiquitinase Ubiquitin‐Specific Protease 29 Ameliorates Pathological Cardiac Hypertrophy through Inhibiting Transforming Growth Factor β‐Activated Kinase 1
by: Xi Jiang, et al.
Published: (2025-03-01) -
Emerging Role of Targeting Deubiquitinating Enzymes to Inhibit Pathological Cardiac Hypertrophy
by: Ren Ping Liu, et al.
Published: (2025-03-01) -
TRIM26 exacerbates pathological cardiac hypertrophy by activating TAK1
by: Xiaochuang Xia, et al.
Published: (2025-01-01) -
USP10 protects against pressure overload-induced mitochondrial morphofunctional defects and pathological cardiac hypertrophy through stabilizing cytoplasmic Mfn2
by: Runjing Li, et al.
Published: (2025-09-01)